Sat, Jan 16, 2021
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Gramercy Funds Management names Mohamed A. El-Erian as senior advisor

Wednesday, April 24, 2019
Opalesque Industry Update - Gramercy Funds Management LLC, a $6 billion dedicated emerging markets investment manager, today announced that Dr. Mohamed A. El-Erian will be involved with the firm on a part-time basis as a Senior Advisor.

Dr. El-Erian is a renowned economist and leader in emerging markets investment and research, having previously held senior roles in investment management and international policymaking. He was on Foreign Policy's list of Top 100 Global Thinkers for four years in a row. In his new role at Gramercy, Dr. El-Erian will provide valuable insight, commentary and guidance on a range of global economic, market and geo-political topics. He will also advise on policy and investment trends, as well as other forces shaping this diverse asset class.

"I'm delighted and honored to have the opportunity to engage with Gramercy, a firm that I have admired for several years and whose approach to emerging markets, one of my passions, is thoughtful, imaginative and effective," said Dr. El-Erian.

"We are incredibly grateful to welcome Mohamed as a Senior Advisor," said Robert Koenigsberger, Founder and Chief Investment Officer of Gramercy. "He is a distinguished industry veteran with invaluable knowledge and understanding of emerging markets. We look forward to leveraging Mohamed's development of top down themes that will be an important element to the performance of our portfolios and his assistance with PMs and analysts on decoding macro themes and their impact on our investments in EM."

Dr. El-Erian was most recently CEO and Co-Chief Investment Officer of PIMCO (2007-14), which he originally joined in 1999 to lead its emerging markets portfolio management business. Dr. El-Erian served as Chairman of the U.S. Government's Global Development Council under President Obama, spent 15 years at the International Monetary Fund, where he was a Deputy Director, and was CEO and President of the Harvard Management Company. He also spent time as a managing director at Salomon Smith Barney/Citigroup in London. Dr. El-Erian is a member of the IMF's External Advisory Group on Surveillance and MIT's Visiting Committee for the Department of Economics, and sits on several non-profit boards as well as Under Armour's. He is a contributing editor at the Financial Times and a columnist at Bloomberg, in addition to having written two best-selling books on economics and finance.

Dr. El-Erian received a B.A. and an M.A. from Cambridge University in economics, and an M.Phil and doctorate from Oxford University.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. SPACs: The SPAC shareholder class action boom is coming, SPACs have a hidden risk that investors need to know about[more]

    The SPAC shareholder class action boom is coming From Reuters: I'm not the first to predict it, but the past few weeks have brought unmistakable signs that shareholder class action firms are homing in on Special Purpose Acquisition Companies, those so-called blank-check entities that g

  2. SPACs: Jeremy Grantham: "SPACs should be illegal", Spacs may fuel European IPO boom, SPAC IPOs surge, The SPAC pop is now a thing: More unicorns getting on board, Paysafe readies $9bn IPO Via SPAC[more]

    Jeremy Grantham: "SPACs should be illegal" Special-purpose acquisition companies (SPACs) should be illegal, according to Jeremy Grantham, as they escape regulatory oversight and encourage the "most obscene type of investing." Grantham is the co-founder and chief investment strategi

  3. News Briefs: What if data scientists had licenses like lawyers?, Next generation behind family offices' ESG push[more]

    What if data scientists had licenses like lawyers? From Bloomberg: Data scientists, if they're poorly qualified or act irresponsibly, can do at least as much damage as lawyers and doctors. The algorithms they create can ruin lives, aggravate social divisions, even facilitate genocide.

  4. SPACs: SPAC costs are 'far higher' than previously realized, study finds, Jim Cramer recommends profit taking in speculative electric SPAC names.[more]

    SPAC costs are 'far higher' than previously realized, study finds From Institutional Investor: The costs of going public via a special-purpose acquisition company are both "opaque and far higher" than previously recognized, new research shows. SPAC shares tend to drop by one third or

  5. Institutional Investors: Pensions swamped in a sea of negative real rates, Bahrain's pension fund authority faces collapse[more]

    Pensions swamped in a sea of negative real rates From FA Mag: Defined-benefit pension plans were already barely treading water heading into 2020. In the years ahead, the risk is as great as ever that a large swath of them will drown. As the name implies, defined-benefit pensions promis